Everest Venture Capital
VC Fund
Beijing, China
Everest Venture Capital is a VC fund in Beijing focused on Information Technology and Software. Everest Venture Capital Investment Co.,Ltd was founded by Mr.Xiao Jiancong in September 2007. The founder and his team focus on high-tech venture capital investments for the past 12 years. In 2018, Everest Venture capital was awarded with the top 10 most active private equity investment institutions and the top 50 best venture capital institutionsin China. They have 140 employees with rich industrial experience, and two offices in both Beijing and Shenzhen to cover the investments in the whole Mainland China area.Everest Venture Capital has achieved a great social value of Science and Technology. They only invest the enterprises with positive value for society. At the same time, they also keep the value proposition that they won’t sell the future for a short-term profit. Regarding the founder of enterprise whom they invested, they not only inject funds but also inject the management style of being excellent. They always share their unique management philosophy with their portfolio companies about the ideas “three-high and one-low”--high satisfaction degree from customers, high rate of return for shareholders, high salary income to employees, and low comprehensive cost. And they believe these will define the greatness of enterprise ultimately.
- Total investments:
- 127
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Everest Venture Capital invests in
Stages Everest Venture Capital invests in
Countries Everest Venture Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $1.4M–$30M
- Series B
- $1.7M–$38M
- Series C
- $2.8M–$78M
Investment Focus
Industry
- Information Technology 23 (18%)
- Software 20 (16%)
- Manufacturing 20 (16%)
- Health Care 15 (12%)
- Medical 13 (10%)
Stage
- Series A 33 (26%)
- Series B 26 (20%)
- Series C 20 (16%)
- Angel 12 (9%)
- Seed 9 (7%)
Country
- China 104 (82%)
- United States 2 (2%)
- France 1 (1%)
- Germany 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Chen Xin
Partner
|
Partner | Total investments: 1 | Find email | |
Jiancong Xiao
Founder
|
Founder | Total investments: 4 | Find email | |
Kai Shen
Co-founder
|
Co-founder | Total investments: 0 | Find email | |
|
Li Weiwei
Partner
|
Partner | Total investments: 3 | Find email | |
Lv Zhaojian
Partner
|
Partner | Total investments: 1 | Find email | |
| See all 9 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
BoPixel
|
BoPixel is a supplier of high-performance machine vision core components, stable, reliable and machine vision products for global customers. | Series C / Aug 06, 2026 | |
VelaVigo
|
VelaVigo is a start-up company engaged in macromolecular biopharmaceuticals. | $60M / Seed / Jul 28, 2025 | |
Suzhou Ribo Life Science
|
Suzhou Ribo Life Science is a developer of RNA interference ( RNAi ) technology designed to treat liver diseases. The company's RNA interference ( RNAi ) technology is used to develop nucleic acid therapeutic drugs and related products, enabling healthcare providers to deliver more effective pharmaceuticals to patients. | $27.9M / Series E / Jul 21, 2025 | |
Gritworld
|
Push the boundaries of real time graphics and computer visionThey facilitate seamless data transfer from industry standard data formats to real time high quality computer graphics and vision engines formats, in order to dramatically improve the efficiency and quality of real time data simulation, visualization and standardization.They helpindustry technology leaders to research and develop key technologies in computer graphics and vision, VR and AR. | Series B / Jul 17, 2025 | |
Tongee Medical Technology
|
Tongee Medical Technology develops new medical technologies to treat various metabolic diseases, such as obesity, type 2 diabetes, and nonalcoholic fatty liver. | $13.6M / Series C / Feb 05, 2025 | |
|
Tongee Medical Technology
|
Tongee Medical Technology develops new medical technologies to treat various metabolic diseases, such as obesity, type 2 diabetes, and nonalcoholic fatty liver. | $13.6M / Series C / Feb 05, 2025 | |
Huixi Intelligent
|
Huixi Intelligent focuses on autonomous driving chips, and its products include chip computing platforms, autonomous driving software solutions, and development tool chains. | Series A / Jan 08, 2025 | |
|
BoPixel
|
BoPixel is a supplier of high-performance machine vision core components, stable, reliable and machine vision products for global customers. | $18.2M / Series A / Aug 21, 2024 | |
X-MAGTECH
|
X-MAGTECH is a technology platform for measuring extremely weak magnetic fields. | $13.7M / Series A / Jul 22, 2024 | |
Jiangxing Intelligence
|
Jiangxing Intelligence was founded in 2018 by internationally renowned scientists, academician of the Canadian Academy of Engineering, and IEEE Fellow Professor Liu Jiangchuan. The company is committed to the development of advanced edge computing technology and its application in the fields of energy Internet, industrial security, and intelligentwarehousing. At the beginning of the company's establishment, it has obtained tens of millions of venture capital from Sequoia Capital China Seed Fund. | Series B / Jun 10, 2024 | |
| See all 127 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Everest Venture Capital invest in?
Everest Venture Capital invests primarily in Information Technology, Software and Manufacturing startups, most often at Series A and Series B stage. Most of the 127 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Everest Venture Capital's check size?
Everest Venture Capital typically joins rounds of $1.4M–$30M at Series A, $1.7M–$38M at Series B and $2.8M–$78M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Everest Venture Capital participates in.
How do I contact Everest Venture Capital?
Public channels for Everest Venture Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Everest Venture Capital?
The team at Everest Venture Capital includes Chen Xin (Partner), Jiancong Xiao (Founder) and Kai Shen (Co-founder), among 9 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
